It's not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock ...

A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...

Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle ...

So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays ...

It's too early to know how well the method would work in people—but it just might be possible to one day swap out needles for ...

(HealthDay News) — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some individuals, according to a study published online in ...

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

A study published in the New England Journal of Medicine has suggested semaglutide can improve knee pain in people with obesity and OA.

Compounded GLP-1 medications are typically safe for most people. But since compounded GLP-1s aren’t FDA-approved, the FDA ...

Here are four things to know about knee pain and GLP-1s based on studies and surgeon observations from 2024: ...

The startup, Pep2Tango, is combining four methods of accelerating weight loss into one medicine in the hopes of developing a ...

Surprising research strongly suggests semaglutide can help fight substance use disorder. Why aren't we using it?